1. Assessment of the targeting specificity of a fluorescent albumin conceived as a preclinical agent of the liver function. Issue 45 (8th November 2018) Authors: Lemdani, K.; Salmon, H.; Gahoual, R.; Bessodes, M.; Scherman, D.; Houzé, P.; Seguin, J.; Mignet, N. Journal: Nanoscale Issue: Volume 10:Issue 45(2018) Page Start: 21151 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. OP0220 Innovative anti-inflammatory strategy in arthritis using PBEF sirna-mediated silencing in LY-6CHIGH monocytes. (23rd January 2014) Authors: Presumey, J.; Courties, G.; Charbonnier, L.-M.; Escriou, V.; Scherman, D.; Pers, Y.-M.; Louis-Plence, P.; Yssel, H.; Pène, J.; Kyburz, D.; Gay, S.; Jorgensen, C.; Apparailly, F. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 130 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗